November 4, 2020 -- Thermo Fisher Scientific and Northeastern University have partnered to advance analytical capabilities and boost the biopharmaceutical industry.
The partnership aims to drive the industry in the areas of personalized medicine, monoclonal antibodies, and gene and cell therapies. Part of the agreement includes implementing Thermo Fisher's Orbitrap Exploris 240 mass spectrometer and Vanquish Duo ultra-high performance liquid chromatography (UHPLC) system within Northeastern's Biopharmaceutical Analysis Training Laboratory.
The equipment will help analyze the complex molecules defining the medicines of the future and will help those in the lab develop chromatography-based workflows for the streamlined analysis of biotherapeutics.
Copyright © 2020 scienceboard.net